Skip to main content
Home / Current Pharmaceutical Biotechnology, Volume 3, Number 3
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 3, Number 3, 2002

Review article

Management of Acute and Chronic Open Wounds: The Importance of Moist Environment in Optimal Wound Healing
pp. 179-195(17)
Authors: Atiyeh, B.S.; Ioannovich, J.; Al-Amm, C.A.; El-Musa, K.A.

Favourites:
ADD

Drugs that Inhibit Mycolic Acid Biosynthesis in Mycobacterium tuberculosis
pp. 197-225(29)
Authors: Schroeder, E.K.; de Souza, O.N.; Santos, D.S.; Blanchard, J.S.; Basso, L.A.

Favourites:
ADD

Encapsulating DNA within Biodegradable Polymeric Microparticles
pp. 227-235(9)
Authors: Lengsfeld, C.S.; Manning, M.C.; Randolph, T.W.

Favourites:
ADD

Engineering Antibodies for Therapy
pp. 237-256(20)
Author: Presta, L.G.

Favourites:
ADD

Localised Delivery of Therapeutic Agents to CNS Malignancies: Old and New Approaches
pp. 257-273(17)
Authors: Read, T-A.; Thorsen, F.; Bjerkvig, R.

Favourites:
ADD

Modulating Poly (ADP-Ribose) Polymerase Activity: Potential for the Prevention and Therapy of Pathogenic Situations Involving DNA Damage and Oxidative Stress
pp. 275-283(9)
Authors: Decker, P.; Muller, S.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content